Scientific Sessions 2025  /  Shifting Paradigms in Lipid Management for ASCVD Risk  /  CORALreef Lipids Discussant
Logo

American Heart Association

  52
  0

Final ID:

CORALreef Lipids Discussant

  • Lloyd-jones, Donald  ( Boston University Medical Center , Boston , Massachusetts , United States )
    • Author Disclosures:
    Donald Lloyd-Jones: DO have relevant financial relationships ; Employee:American Heart Association:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Shifting Paradigms in Lipid Management for ASCVD Risk

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Main Event

More abstracts on this topic:
Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, for Lowering LDL Cholesterol in Adults with or At-Risk for ASCVD: The Phase 3 CORALreef Lipids Trial

Navar Ann Marie, Mendizabal Geraldine, Nuez Llota Julio, Zhu Pengfei, Zhuo Min, Ballantyne Christie, Mikhailova Elina, Catapano Alberico, Banka Puja, Blom Dirk, Cadena Alberto, Kourpanidis Susan, Lepor Norman, Tsukamoto Kazuhisa

Lp(a) and ASCVD: What does the causal link mean for risk reduction in practice?

O'donoghue Michelle

More abstracts from these authors:
Turning Guidelines into Practice: How Do We Make It Happen?

Lloyd-jones Donald

Words of wisdom - connecting the dots

Lloyd-jones Donald

You have to be authorized to contact abstract author. Please, Login
Not Available